Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;55(1):47-55.
doi: 10.1159/000512647. Epub 2021 Jan 21.

Duchenne and Becker Muscular Dystrophies' Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences

Affiliations

Duchenne and Becker Muscular Dystrophies' Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences

Yanan Zhang et al. Neuroepidemiology. 2021.

Abstract

Introduction: Previous studies indicated variability in the prevalence of Duchenne and Becker muscular dystrophies (DBMD) by racial/ethnic groups. The Centers for Disease Control and Prevention's (CDC) Muscular Dystrophy Surveillance, Tracking, and Research network (MD STARnet) conducts muscular dystrophy surveillance in multiple geographic areas of the USA and continues to enroll new cases. This provides an opportunity to continue investigating differences in DBMD prevalence by race and ethnicity and to compare the impact of using varying approaches for estimating prevalence.

Objective: To estimate overall and race/ethnicity-specific prevalence of DBMD among males aged 5-9 years and compare the performance of three prevalence estimation methods.

Methods: The overall and race/ethnicity-specific 5-year period prevalence rates were estimated with MD STARnet data using three methods. Method 1 used the median of 5-year prevalence, and methods 2 and 3 calculated prevalence directly with different birth cohorts. To compare prevalence between racial/ethnic groups, Poisson modeling was used to estimate prevalence ratios (PRs) with non-Hispanic (NH) whites as the referent group. Comparison between methods was also conducted.

Results: In the final population-based sample of 1,164 DBMD males, the overall 5-year prevalence for DBMD among 5-9 years of age ranged from 1.92 to 2.48 per 10,000 males, 0.74-1.26 for NH blacks, 1.78-2.26 for NH whites, 2.24-4.02 for Hispanics, and 0.61-1.83 for NH American Indian or Alaska Native and Asian or Native Hawaiian or Pacific Islander (AIAN/API). The PRs for NH blacks/NH whites, Hispanics/NH whites, and NH AIAN/API/NH whites were 0.46 (95% CI: 0.36-0.59), 1.37 (1.17-1.61), and 0.61 (0.40-0.93), respectively.

Conclusions: In males aged 5-9 years, compared to the prevalence of DBMD in NH whites, prevalence in NH blacks and NH AIAN/API was lower and higher in Hispanics. All methods produced similar prevalence estimates; however, method 1 produced narrower confidence intervals and method 2 produced fewer zero prevalence estimates than the other two methods.

Keywords: Duchenne-Becker muscular dystrophy; Epidemiology; Race/ethnicity.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1.
Fig. 1.
5-year prevalence of Duchenne and Becker muscular dystrophy among males aged 5 to 9 years by race/ethnicity and three estimating methods, the Muscular Dystrophy Surveillance, Tracking, and Research network (MD STARnet). The lines at the top of each bar are 95% confidence intervals. AIAN = American Indian or Alaska Native & Native Hawaiian. API = American Pacific Islander.

References

    1. Flanigan KM. Duchenne and Becker muscular dystrophies. Neurologic clinics. 2014;32(3):671–88, viii. - PubMed
    1. Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet journal of rare diseases. 2017;12(1):79. - PMC - PubMed
    1. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988;2(1):90–5. - PubMed
    1. Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. Journal of paediatrics and child health. 2015;51(8):759–64. - PubMed
    1. U.S. Department of Health & Human Services NIoH, NCATS. Becker muscular dystrophy 2016 [2019/July/16]. Available from: https://rarediseases.info.nih.gov/diseases/5900/becker-muscular-dystrophy.

Publication types